What it sells
Data analytics software for biomanufacturing.
Business model breakdown
Buyer: who owns the budget?
UnverifiedHeads of process development, MSAT and digital/R&D leadership at biopharma and CDMOs.
Trigger: what makes them buy now?
Scientists spend over 50% of time managing data; digital twin / data integration projects stall (e.g. an AVEVA PI integration quoted at 6 months minimum).
Workflow: what inputs become what output?
Connect instruments and systems, align timestamps and normalize units automatically, browse a run directory across unit ops, then use AI to answer questions, write reports or train predictive models.
Economics: what it saves and how it charges
Priced around customer stack, not seats. Claimed value: 3,046 hours saved per program (CMC Biologics), $2M+ digital twin investment unlocked, $400K costs avoided.
Distribution: how it reaches customers
Demo-led sales (Book a demo), plus a free Invert Assist trial as a self-serve entry.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Winter 2022 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.